AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Infrared Photobiomodulation in Humans With Epilepsy

RecruitingNAAges 18 Years - anyAllBeth Israel Deaconess Medical Center
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Drug-resistant epilepsy represents roughly 40% of people with epilepsy. It is very challenging to stop seizures in this condition, and the treatment options are limited. This study aims to investigate a new treatment that involves using infra-red light. In animals, this treatment has shown promise as a possible way to reduce seizures, but it has not been tested in humans for this. The investigators are interested to know if it can reduce seizures, and how comfortable it is to be treated with this therapy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Drug resistant epilepsy * Age 18 or older * Average seizure rate of at least 2 seizures per month * Accurate seizure diary with at least 3 months recorded Exclusion Criteria: * Implanted intracranial neurostimulation device (DBS or RNS) * Intracranial shunt * Skin photosensitivity * Cancer on scalp * Taking any medication that can cause photosensitivity
๐Ÿ’Š

What it tests

  • photobiomodulation
๐Ÿ“

Where

1 site
BIDMC
Boston, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy